Quidel Corporation
http://www.quidel.com
Already a Biomedtracker subscriber?
You have access to the full company record through your subscription
Want to become a subscriber?
Subscribers get more company details, updates, company financials and company products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Quidel Corporation
Point Of Care Diagnostics Market Projected To Continue Rapid Growth
A new report from Informa's Meddevicetracker highlights strong projected growth in the market, explaining the underlying reasons why.
NIH, CDC Distributing OTC COVID-19 Tests In US Study On Reducing Community Transmission
NIH pays for 2 million Quidel QuickVue tests in a program it is conducting with the CDC to determine whether frequent self-administered testing helps reduce community transmission of SARS-CoV-2.
Abbott, BD, Quidel OTC COVID-19 Tests Granted Emergency Use Authorization In US
FDA grants emergency use authorization to OTC COVID-19 testing products as it targets allowing workplaces, schools and communities to access tools needed to screen for the virus rapidly and accurately.
FDA Grants Emergency Use Authorization To Variety Of OTC COVID-19 Tests
The US agency has granted emergency use authorization to consumer COVID-19 testing products from Quidel, Abbott and BD.
Company Information
- Industry
-
In Vitro Diagnostics
- Chemistry, Immunoassay
- Cytology
- Molecular Diagnostics & Genetic Testing
- Therapeutic Drug Monitoring
- Other Names / Subsidiaries
-
- AnDiaTec
- BioHelix Corporation
- Diagnostic Hybrids, Inc.